This paper investigates whether a “Golden Rule” of regulation of an infectious disease may be elicited that balances the economic control and disease costs when the arrival of a future vaccine or a cure is uncertain. Formulating an optimal control problem applied to standard compartment...

The article presents a summary of the research results of the project on the development of the COVID-19 pandemic in Poland in its initial phase (March-June 2020). It argues that the design and timing of regulatory responses, as well as the adherence of the population to the relevant rules, had...

EU law incentivises drug marketing authorisation holders (MAHs) to find new uses for their compounds (research known as ‘‘repositioning’’) by offering them an extra year of market protection if the new use is authorised. This extra year, known as the ‘‘+1’’, was enacted on...

The demand for healthcare is increasing globally. In India, a dual burden of communicable and non-communicable diseases along with an ageing population is affecting the demand for healthcare. Concerns for providing efficient and effective healthcare to the vulnerable population has led to the...

The cloning of farm animals is occurring in Australia and is raising significant concerns regarding both the cloning and sale of food products from clones. Concerns include: the health risks to clones and other animals involved in the procedure; any adverse impact on the genetic diversity of the...

The established role of pharmaceutical products in the current health care landscape combined with increasing reports of serious and often fatal toxicity associated with these products have led to growing calls for reform of drug regulation. The growing public-private partnerships in research...

Prior marketing literature has overlooked the role of regulatory regimes in explaining international sales growth of new products. This paper addresses this gap in the context of new pharmaceuticals (15 new molecules in 34 countries) and sheds light on the effect regulatory regimes have on new...

Regulation is a high-stakes enterprise marked by tremendous challenges and relentless public pressure. Regulators are expected to protect the public from harms associated with economic activity and technological change without unduly impeding economic growth or efficiency. Regulators today also...

Health care is beset with an array of market failures (e.g., informational asymmetries, externalities, monopolization, and public goods). In theory, government can intervene to fix these market failures, allowing scarce resources to be devoted to their highest use at the lowest possible cost...

Social protection in industrial countries has been provided through regulations, tax expenditures, and public spending. This paper argues that globalization will affect governments` ability to continue providing this social protection at the level of recent decades. Specifically, tax competition...